Optimere hæmostase

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Kilde‎: N Engl J Med 2017;376(2):136-48.

Indekseret‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (åbner nyt vindue)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (åbner nyt vindue)

Nurözler F, Kutlu T, Küçük G.

Kilde‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Indekseret‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (åbner nyt vindue)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (åbner nyt vindue)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Kilde‎: JAMA Surg 2013;148(6):538-47.

Indekseret‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (åbner nyt vindue)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (åbner nyt vindue)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Kilde‎: JAMA. 2022;328(4):336-47.

Indekseret‎: PubMed 35881121

DOI‎: 10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (åbner nyt vindue)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (åbner nyt vindue)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Kilde‎: Anesth Analg 2012;115(2):239-43.

Indekseret‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (åbner nyt vindue)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (åbner nyt vindue)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Kilde‎: Ann Thorac Surg 2010;89(5):1489-95.

Indekseret‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (åbner nyt vindue)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (åbner nyt vindue)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Kilde‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Indekseret‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (åbner nyt vindue)

Rekombinant aktiveret Faktor VII (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (åbner nyt vindue)

Ballen J, Raabe M, Muirhead B.

Kilde‎: Can J Anaesth 2006;53(4):353-6.

Indekseret‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (åbner nyt vindue)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (åbner nyt vindue)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Kilde‎: Transfusion 2013;53(4):798-804.

Indekseret‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (åbner nyt vindue)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (åbner nyt vindue)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Kilde‎: Ann Thorac Surg 2008;85(3):836-44.

Indekseret‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (åbner nyt vindue)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (åbner nyt vindue)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Kilde‎: Can J Cardiol 2011;27(6):869.e7-8.

Indekseret‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (åbner nyt vindue)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (åbner nyt vindue)

Flynn BC, Steiner ME, Mazzeffi M

Kilde‎: Anesthesiology. 2023 1;139(2):197-210.

Indekseret‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (åbner nyt vindue)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (åbner nyt vindue)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Kilde‎: Circulation 2009;120(1):21-7.

Indekseret‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (åbner nyt vindue)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (åbner nyt vindue)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Kilde‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Indekseret‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (åbner nyt vindue)

Off-label use of recombinant human factor VIIa. (åbner nyt vindue)

Goodnough LT, Levy JH.

Kilde‎: Ann Thorac Surg 2014;98(2):393-5.

Indekseret‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (åbner nyt vindue)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (åbner nyt vindue)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Kilde‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Indekseret‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (åbner nyt vindue)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (åbner nyt vindue)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Kilde‎: Circulation 2008;118(4):331-8.

Indekseret‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (åbner nyt vindue)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (åbner nyt vindue)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Kilde‎: J Vasc Surg 2011;53(4):1032-7.

Indekseret‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (åbner nyt vindue)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (åbner nyt vindue)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Kilde‎: Transfus Med Hemother 2012;39(2):139-50.

Indekseret‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (åbner nyt vindue)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (åbner nyt vindue)

Lehr EJ, Alford TJ, Wang SH.

Kilde‎: Heart Surg Forum 2010;13(5):E275-9.

Indekseret‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (åbner nyt vindue)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (åbner nyt vindue)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Kilde‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Indekseret‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (åbner nyt vindue)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (åbner nyt vindue)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Kilde‎: Drugs R D 2015;15(2):187-94.

Indekseret‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (åbner nyt vindue)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (åbner nyt vindue)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Kilde‎: A A Case Rep 2015;5(1):3-5.

Indekseret‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (åbner nyt vindue)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (åbner nyt vindue)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Kilde‎: Anesthesiology 2003;98(6):1513-5.

Indekseret‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (åbner nyt vindue)

Recombinant activated factor VII in cardiac surgery: a systematic review. (åbner nyt vindue)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Kilde‎: Ann Thorac Surg 2007;83(2):707-14.

Indekseret‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (åbner nyt vindue)

Koagulationsfaktor-koncentrater

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (åbner nyt vindue)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Kilde‎: Transfusion 2014;54(5):1348-57.

Indekseret‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (åbner nyt vindue)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (åbner nyt vindue)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Kilde‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Indekseret‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (åbner nyt vindue)

Reducing blood transfusion in aortic surgery: a novel approach. (åbner nyt vindue)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Kilde‎: Ann Thorac Surg 2019;108(5):1369-75.

Indekseret‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (åbner nyt vindue)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (åbner nyt vindue)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Kilde‎: Ann Thorac Surg 2009;88(5):1666-8.

Indekseret‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (åbner nyt vindue)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (åbner nyt vindue)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Kilde‎: Crit Care 2016;20:5.

Indekseret‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (åbner nyt vindue)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (åbner nyt vindue)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Kilde‎: A A Case Rep 2015;4(10):140-2.

Indekseret‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (åbner nyt vindue)

State of the art - how I manage coagulopathy in cardiac surgery patients. (åbner nyt vindue)

Davidson S.

Kilde‎: Br J Haematol 2014;164(6):779-89.

Indekseret‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (åbner nyt vindue)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (åbner nyt vindue)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Kilde‎: Anesthesiology 2011;115(6):1179-91.

Indekseret‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (åbner nyt vindue)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (åbner nyt vindue)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Kilde‎: JAMA Netw Open 2021;4(4):e213936.

Indekseret‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (åbner nyt vindue)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (åbner nyt vindue)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Kilde‎: Thromb Haemost 2009;102(1):137-44.

Indekseret‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (åbner nyt vindue)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (åbner nyt vindue)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Kilde‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Indekseret‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (åbner nyt vindue)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (åbner nyt vindue)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Kilde‎: Anesthesiology 2013;118(1):40-50.

Indekseret‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (åbner nyt vindue)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (åbner nyt vindue)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Kilde‎: J Am Heart Assoc 2015;4(6):e002066.

Indekseret‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (åbner nyt vindue)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (åbner nyt vindue)

Ranucci M, Baryshnikova E.

Kilde‎: Br J Anaesth 2016;116(5):618-23.

Indekseret‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (åbner nyt vindue)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (åbner nyt vindue)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Kilde‎: Can J Anaesth 2012;59(3):299-303.

Indekseret‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (åbner nyt vindue)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (åbner nyt vindue)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Kilde‎: Ann Thorac Surg 2019;107(4):1275-83.

Indekseret‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (åbner nyt vindue)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (åbner nyt vindue)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Kilde‎: Anesth Analg 2007;104(4):763-5.

Indekseret‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (åbner nyt vindue)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (åbner nyt vindue)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Kilde‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indekseret‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (åbner nyt vindue)

Desmopressin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (åbner nyt vindue)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Kilde‎: Anaesthesia 2010;65(7):688-91.

Indekseret‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (åbner nyt vindue)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (åbner nyt vindue)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Kilde‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indekseret‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (åbner nyt vindue)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (åbner nyt vindue)

Wademan BH, Galvin SD.

Kilde‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Indekseret‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (åbner nyt vindue)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (åbner nyt vindue)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Kilde‎: Anesth Analg 2010;110(3):702-7.

Indekseret‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (åbner nyt vindue)

Topiske hæmostatika

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (åbner nyt vindue)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Kilde‎: Ann Surg 2010;251(2):217-28.

Indekseret‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (åbner nyt vindue)

A review of topical hemostatic agents for use in cardiac surgery. (åbner nyt vindue)

Barnard J, Millner R.

Kilde‎: Ann Thorac Surg 2009;88(4):1377-83.

Indekseret‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (åbner nyt vindue)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (åbner nyt vindue)

Forcillo J, Perrault LP.

Kilde‎: Transfus Apher Sci 2014;50(1):26-31.

Indekseret‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (åbner nyt vindue)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (åbner nyt vindue)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Kilde‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Indekseret‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (åbner nyt vindue)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (åbner nyt vindue)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Kilde‎: Innovations (Phila) 2012;7(4):229-41.

Indekseret‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (åbner nyt vindue)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (åbner nyt vindue)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Kilde‎: J Card Surg 2009;24(6):722-4.

Indekseret‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (åbner nyt vindue)

Topical haemostatic agents. (åbner nyt vindue)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Kilde‎: Br J Surg 2008;95(10):1197-225.

Indekseret‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (åbner nyt vindue)

Viskoelastiske test til identificering af kirurgisk blødning og koagulationsdefekt

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (åbner nyt vindue)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Kilde‎: Transfus Med 2006;16(1):31-9.

Indekseret‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (åbner nyt vindue)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (åbner nyt vindue)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Kilde‎: Anesthesiology 2011;115(6):1179-91.

Indekseret‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (åbner nyt vindue)

Management of hemorrhage in cardiothoracic surgery. (åbner nyt vindue)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Kilde‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Indekseret‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (åbner nyt vindue)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (åbner nyt vindue)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Kilde‎: Anesthesiology 2012;117(3):531-47.

Indekseret‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (åbner nyt vindue)

THORAX-, HJERTE- OG KARKIRURGI

Optimere hæmostase

Dansk

Optimere hæmostase

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Antifibrinolytika

Rekombinant aktiveret Faktor VII (rFVIIa)

Koagulationsfaktor-koncentrater

Desmopressin

Topiske hæmostatika

Viskoelastiske test til identificering af kirurgisk blødning og koagulationsdefekt

Vælg dit sprog

Del